NCT00996021 - Study to Assess Cardiac Conduction of GSK1349572 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

December 31, 2009

Conditions

Healthy Subjects

Interventions

DRUG

GSK1349572 250 mg

This is an experimental HIV medication in the integrase inhibitor class.

DRUG

Placebo Suspension

Placebo is a liquid with no drug in it.

DRUG

Moxifloxacin 400 mg

This is an FDA approved antibiotic in the fluoroquinolone class.

Trial Locations (1)

GSK Investigational Site, Baltimore